"Serious Faults" In Novartis Pharma K.K. (NVS) Clinical Study Of Leukemia Drug: Panel
6/26/2014 5:55:13 AM
TOKYO (Kyodo) -- Novartis Pharma K.K. violated Japan's personal information protection law and ethical guidelines in a clinical study, led by the University of Tokyo, of a leukemia drug, the university's investigation panel said Tuesday.
Following release of its final report, the university will consider punishing those responsible, a university official said.
Help employers find you! Check out all the jobs and post your resume.
comments powered by